Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures—a short review I Svíženská, P Dubový, A Šulcová Pharmacology Biochemistry and Behavior 90 (4), 501-511, 2008 | 599 | 2008 |
Biphasic effects of anandamide E Sulcova, R Mechoulam, E Fride Pharmacology Biochemistry and Behavior 59 (2), 347-352, 1998 | 331 | 1998 |
Cannabinoids and cytochrome P450 interactions O Zendulka, G Dovrtelova, K Nosková, M Turjap, A Sulcova, L Hanus, ... Current drug metabolism 17 (3), 206-226, 2016 | 282 | 2016 |
Endocannabinoid system and mood disorders: priming a target for new therapies V Micale, V Di Marzo, A Sulcova, CT Wotjak, F Drago Pharmacology & therapeutics 138 (1), 18-37, 2013 | 257 | 2013 |
Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251 J Vinklerová, J Nováková, A Šulcová Journal of psychopharmacology 16 (2), 139-143, 2002 | 91 | 2002 |
Drug effects on attack, defense and escape in mice M Kršiak, A Šulcová, Z Tomašíková, N Dlohožková, E Kosař, K Mašek Pharmacology Biochemistry and Behavior 14, 47-52, 1981 | 83 | 1981 |
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia T Stark, J Ruda-Kucerova, FA Iannotti, C D'Addario, R Di Marco, V Pekarik, ... Neuropharmacology 146, 212-221, 2019 | 79 | 2019 |
HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenialike animals J Večeřa, E Bártová, J Krejčí, S Legartová, D Komůrková, ... Journal of cellular physiology 233 (1), 530-548, 2018 | 76 | 2018 |
Endogenous cannabinoid ligands—chemical and biological studies R Mechoulam, SB Shabat, L Hanuš, E Fride, Z Vogel, M Bayewitch, ... Journal of lipid mediators and cell signalling 14 (1-3), 45-49, 1996 | 76 | 1996 |
The use of cannabinoids in animals and therapeutic implications for veterinary medicine: a review L Landa, A Sulcova, P Gbelec Veterinární medicína 61 (3), 111-122, 2016 | 75 | 2016 |
Sex differences in the reinstatement of methamphetamine seeking after forced abstinence in Sprague-Dawley rats J Ruda-Kucerova, P Amchova, Z Babinska, L Dusek, V Micale, A Sulcova Frontiers in psychiatry 6, 91, 2015 | 74 | 2015 |
Can social and agonistic interactions be used to detect anxiolytic activity of drugs? M Krsiak, A Sulcova, P Donat, Z Tomasikova, N Dlohozkova, E Kosar, ... Progress in clinical and biological research 167, 93-114, 1984 | 69 | 1984 |
Leading compounds for the validation of animal models of psychopathology V Micale, J Kucerova, A Sulcova Cell and Tissue Research 354 (1), 309-330, 2013 | 67 | 2013 |
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia C D'Addario, V Micale, M Di Bartolomeo, T Stark, M Pucci, A Sulcova, ... Schizophrenia research 188, 132-140, 2017 | 64 | 2017 |
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment T Stark, M Di Bartolomeo, R Di Marco, E Drazanova, CBM Platania, ... Biochemical Pharmacology 177, 114004, 2020 | 52 | 2020 |
Differential effects of six structurally related benzodiazepines on some ethological measures of timidity, aggression and locomotion in mice M Krsiak, A Sulcova Psychopharmacology 101, 396-402, 1990 | 52 | 1990 |
Impact of repeated methamphetamine pretreatment on intravenous self-administration of the drug in males and estrogenized or non-estrogenized ovariectomized female rats J Kucerova, D Vrskova, A Sulcova Neuroendocrinology Letters 30 (5), 663, 2009 | 50 | 2009 |
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic … P Amchova, J Kucerova, V Giugliano, Z Babinska, MT Zanda, M Scherma, ... Frontiers in pharmacology 5, 44, 2014 | 46 | 2014 |
Effect of St John's wort (Hypericum perforatum) on cytochrome P-450 activity in perfused rat liver M Dostálek, J Pistovcakova, J Jurica, J Tomandl, I Linhart, A Sulcova, ... Life sciences 78 (3), 239-244, 2005 | 46 | 2005 |
Involvement of cannabinoid CB1 and CB2 receptor activity in the development of behavioural sensitization to methamphetamine effects in mice. L Landa, A Sulcova, K Slais Neuro endocrinology letters 27 (1-2), 63-69, 2006 | 40 | 2006 |